Your browser doesn't support javascript.
Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries.
Demichelis-Gómez, Roberta; Alvarado-Ibarra, Martha; Vasquez-Chávez, Jule; Delgado-López, Nancy; Gómez-Cortés, Cynthia; Espinosa-Bautista, Karla; Cooke-Tapia, Ana; Milán-Salvatierra, Andrea; Gómez-De León, Andrés; Lee-Tsai, Yu Ling; Rosales-López, Daniel; Cabrera-García, Álvaro; Amador-Medina, Fabián; Córdoba-Ramírez, Alejandra; Murrieta-Álvarez, Iván; Solís-Poblano, Juan Carlos; Apodaca-Chávez, Elia; Rangel-Patiño, Juan; Álvarez-Vera, José Luis; Arana-Luna, Luara; De la Peña-Celaya, José Antonio; Espitia-Ríos, María Eugenia; Hernández-Ruiz, Eleazar; Pérez-Zúñiga, Juan Manuel; Peña-López, Estefanía; González-Rivera, Rosa; García-Leyva, María Fernanda; Tejeda-Romero, Mónica; Cruz-Rico, Jorge; Balderas-Delgado, Carolina; Ruíz-Argüelles, Guillermo J; Gómez-Almaguer, David.
  • Demichelis-Gómez R; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Alvarado-Ibarra M; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • Vasquez-Chávez J; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • Delgado-López N; Hospital de Especialidades, Centro Médico Nacional siglo XXI, Mexico City, Mexico.
  • Gómez-Cortés C; Hospital de Especialidades, Centro Médico Nacional siglo XXI, Mexico City, Mexico.
  • Espinosa-Bautista K; Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Cooke-Tapia A; Complejo Hospitalario Doctor Arnulfo Arias Madrid, Panama, Panama.
  • Milán-Salvatierra A; Hospital Juárez de México, Mexico City, Mexico.
  • Gómez-De León A; Universidad Autónoma de Nuevo Léon, Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico.
  • Lee-Tsai YL; Hospital General San Juan de Dios de Guatemala, Guatemala.
  • Rosales-López D; Instituto Guatemalteco de Seguridad Social, Guatemala City, Guatemala.
  • Cabrera-García Á; Hospital Regional de Alta Especialidad de Ixtapaluca, Estado de México, Mexico.
  • Amador-Medina F; Hospital Regional de Alta Especialidad del Bajío, León, Mexico.
  • Córdoba-Ramírez A; Centro de Hematología y Medicina Interna Puebla, Puebla, Mexico.
  • Murrieta-Álvarez I; Centro de Hematología y Medicina Interna Puebla, Puebla, Mexico.
  • Solís-Poblano JC; Hospital de Especialidades CMN "Manuel Ávila Camacho," IMSS Puebla, Mexico.
  • Apodaca-Chávez E; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Rangel-Patiño J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Álvarez-Vera JL; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • Arana-Luna L; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • De la Peña-Celaya JA; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • Espitia-Ríos ME; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • Hernández-Ruiz E; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • Pérez-Zúñiga JM; Centro Médico Nacional 20 de noviembre, ISSSTE, Mexico City, Mexico.
  • Peña-López E; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
  • González-Rivera R; Hospital de Especialidades, Centro Médico Nacional siglo XXI, Mexico City, Mexico.
  • García-Leyva MF; Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Tejeda-Romero M; Hospital Juárez de México, Mexico City, Mexico.
  • Cruz-Rico J; Hospital Juárez de México, Mexico City, Mexico.
  • Balderas-Delgado C; Hospital Regional de Alta Especialidad de Ixtapaluca, Estado de México, Mexico.
  • Ruíz-Argüelles GJ; Centro de Hematología y Medicina Interna Puebla, Puebla, Mexico.
  • Gómez-Almaguer D; Universidad Autónoma de Nuevo Léon, Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico.
JCO Glob Oncol ; 7: 577-584, 2021 04.
Article in English | MEDLINE | ID: covidwho-1199957
ABSTRACT

PURPOSE:

The COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks for infection and mortality. Among patients with malignant diseases, those with hematologic neoplasms are at a higher risk for poor outcomes. The objective of this study was to register treatment modifications associated with the COVID-19 pandemic and their short-term consequences in Latin America.

METHODS:

Multicenter, prospective, observational, cohort study including patients older than 14 years from 14 centers in four countries (Mexico, Peru, Guatemala, and Panama) who had a confirmed diagnosis of acute leukemia, and who were undergoing active treatment since the first COVID-19 case in each country until the cutoff on July 15, 2020.

RESULTS:

We recruited 635 patients. Treatment modifications because of the COVID-19 pandemic were reported in 40.8% of cases. The main reason for such modifications was logistic issues (55.0%) and the most frequent modification was chemotherapy delay (42.0%). A total of 13.1% patients developed COVID-19 disease, with a mortality of 37.7%. Several factors were identified as independently associated with mortality, including a diagnosis of acute myeloid leukemia (odds ratio 2.38 [95% CI, 1.47 to 3.84]; P < .001), while the use of telemedicine was identified as a protective factor (odds ratio 0.36 [95% CI, 0.18 to 0.82]; P = .014).

CONCLUSION:

These results highlight the collateral damage of COVID-19 in oncology patients.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid / SARS-CoV-2 / COVID-19 / Medical Oncology Type of study: Cohort study / Diagnostic study / Etiology study / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Central America / South America / Guatemala / Mexico / Panama / Peru Language: English Journal: JCO Glob Oncol Year: 2021 Document Type: Article Affiliation country: Go.20.00620

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Myeloid / SARS-CoV-2 / COVID-19 / Medical Oncology Type of study: Cohort study / Diagnostic study / Etiology study / Observational study / Prognostic study Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Central America / South America / Guatemala / Mexico / Panama / Peru Language: English Journal: JCO Glob Oncol Year: 2021 Document Type: Article Affiliation country: Go.20.00620